Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Cimpress
CMPR
$2.34B
| $936K | ﹤0.01% |
33,900
-200
| -0.6% | -$5.19K |
|
|
DFSV
2577
Dimensional US Small Cap Value ETF
DFSV
$8.34B
| $934K | ﹤0.01% |
+37,700
| New | +$932K |
|
2578
Nomura Holdings
NMR
$29.1B
| $931K | ﹤0.01% |
248,290
+18,300
| +8% | +$63.2K |
|
2579
NLI Holdings
NL
$310M
| $930K | ﹤0.01% |
136,614
-10,600
| -7% | -$79K |
|
|
NOAH
2580
Noah Holdings
NOAH
$595M
| $927K | ﹤0.01% |
59,800
-700
| -1% | -$10.2K |
|
2581
TAT Technologies
TATT
$516M
| $926K | ﹤0.01% |
174,702
-13,000
| -7% | -$78.9K |
|
2582
Garrett Motion
GTX
$5.64B
| $924K | ﹤0.01% |
121,200
+7,500
| +7% | +$52.7K |
|
2583
Taboola.com
TBLA
$1.13B
| $924K | ﹤0.01% |
300,100
-371,344
| -55% | -$788K |
|
|
QUOT
2584
DELISTED
Quotient Technology Inc
QUOT
| $918K | ﹤0.01% |
+267,500
| New | +$756K |
|
|
AVDX
2585
DELISTED
AvidXchange
AVDX
| $915K | ﹤0.01% |
92,100
-312,000
| -77% | -$2.71M |
|
2586
Compugen
CGEN
$222M
| $912K | ﹤0.01% |
1,273,766
-1,098,882
| -46% | -$959K |
|
|
INN
2587
Summit Hotel Properties
INN
$706M
| $912K | ﹤0.01% |
126,300
-186,232
| -60% | -$1.46M |
|
|
CFB
2588
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $910K | ﹤0.01% |
73,300
+900
| +1% | +$12K |
|
2589
Jones Lang LaSalle
JLL
$16.9B
| $908K | ﹤0.01% |
5,700
-500
| -8% | -$79.7K |
|
2590
Relay Therapeutics
RLAY
$4.17B
| $908K | ﹤0.01% |
+60,800
| New | +$1.16M |
|
2591
Community Bank
CBU
$3.42B
| $907K | ﹤0.01% |
14,403
-64,705
| -82% | -$4.05M |
|
2592
Urban Edge Properties
UE
$2.72B
| $906K | ﹤0.01% |
64,300
-80,400
| -56% | -$1.15M |
|
2593
Peoples Bancorp of North Carolina
PEBK
$227M
| $905K | ﹤0.01% |
27,792
-1,900
| -6% | -$54.1K |
|
2594
Vroom Inc
VRM
$48.5M
| $901K | ﹤0.01% |
11,045
+1,524
| +16% | +$131K |
|
|
UBP
2595
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $898K | ﹤0.01% |
49,300
-4,600
| -9% | -$85.6K |
|
|
CDTX
2596
DELISTED
Cidara Therapeutics
CDTX
| $896K | ﹤0.01% |
59,269
-5,395
| -8% | -$64.4K |
|
|
AFBI
2597
DELISTED
Affinity Bancshares
AFBI
| $894K | ﹤0.01% |
59,204
-5,300
| -8% | -$76.8K |
|
|
EHAB
2598
DELISTED
Enhabit
EHAB
| $891K | ﹤0.01% |
67,700
-6,300
| -9% | -$84K |
|
|
OGI
2599
Organigram Holdings
OGI
$140M
| $891K | ﹤0.01% |
278,291
+43,891
| +19% | +$165K |
|
|
CLPR
2600
Clipper Realty
CLPR
$44.9M
| $889K | ﹤0.01% |
138,857
-10,300
| -7% | -$72.1K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.